Cargando…
Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video‐conference meeting
BACKGROUND: Peritoneal mesothelioma (PM) is a rare primary neoplasm of the peritoneum with an increasing incidence worldwide. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise as a treatment strategy. A national PM multidisciplinary team (national P...
Autores principales: | Brandl, A., Westbrook, S., Nunn, S., Arbuthnot‐Smith, E., Mulsow, J., Youssef, H., Carr, N., Tzivanakis, A., Dayal, S., Mohamed, F., Moran, B.J., Cecil, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093780/ https://www.ncbi.nlm.nih.gov/pubmed/32003132 http://dx.doi.org/10.1002/bjs5.50256 |
Ejemplares similares
-
Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020) -
Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy
por: Tzivanakis, A., et al.
Publicado: (2018) -
Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?
por: Swain, David R., et al.
Publicado: (2018) -
Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei
por: Roy, Ashok, et al.
Publicado: (2019) -
Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis
por: Borie, Raphael, et al.
Publicado: (2019)